Purple Biotech PPBT
NASDAQ PPBT
$1.52 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Purple Biotech (PPBT) Accumulated Expenses (2018 - 2023)

Updated

Purple Biotech (PPBT) posted Accumulated Expenses of $2.52 million for Q4 2023, down 29.9% from $3.6 million a year earlier.

Analysis

Purple Biotech (PPBT) Accumulated Expenses (2018 - 2023) Analysis & Trends

Since Q4 2018, Purple Biotech has reported Accumulated Expenses for 6 quarters.

  • Annual Accumulated Expenses shows a five-year compound annual growth rate of 24.2% (FY2018 to FY2023).
  • In prior years, Purple Biotech's Accumulated Expenses was $3.6 million in FY2022 (+135.6%), $1.53 million in FY2021 (+73.5%), $880,000 in FY2020 (+245.1%) and $255,000 in FY2019 (-70.1%).
  • The Q4 2023 figure stands as the lowest quarterly Accumulated Expenses since Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Purple Biotech 249,214.64 191,214.64 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 2.52 Mn
Dec 31, 2022 3.60 Mn
Dec 31, 2021 1.53 Mn
Dec 31, 2020 880,000.00
Dec 31, 2019 255,000.00
Dec 31, 2018 852,000.00
API Access

Purple Biotech Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=PPBT&period=max&api_key=YOUR_API_KEY